Pulmonary Alveolar Microlithiasis "Stone Lungs": A Case of Clinico-Radiological Dissociation

Andrew Chu1, Sameer Shaharyar1, Binna Chokshi1

  • 1Internal Medicine Department GME, Aventura Hospital and Medical Center.

Cureus
|October 1, 2016
PubMed

Insights

Pulmonary alveolar microlithiasis (PAM) is a rare lung disease causing calcium phosphate buildup. This case highlights severe lung calcification with mild symptoms, a common characteristic of PAM.

Area of Science:

  • Pulmonary Medicine
  • Genetics
  • Radiology

Background:

  • Pulmonary alveolar microlithiasis (PAM) is a rare infiltrative lung disease characterized by the alveolar deposition of calcium phosphate microliths (calcospherites).
  • Pathogenesis is linked to mutations in the SLC34A2 gene, encoding the sodium-phosphate cotransporter.
  • PAM typically affects individuals aged 20-40 and presents with a notable discrepancy between imaging results and clinical presentation.

Observation:

  • A 35-year-old woman presented with back pain and minimal exertional dyspnea following a motor vehicle accident.
  • Radiographic imaging revealed extensive lung calcification.

Findings:

  • Computed tomography and lung biopsy confirmed Pulmonary Alveolar Microlithiasis.
  • The patient exhibited a striking clinico-radiological dissociation, with complete lung calcification on imaging and mild clinical symptoms.

Implications:

  • This case underscores the characteristic dissociation between radiological severity and clinical manifestation in PAM.
  • Highlights the importance of considering PAM in patients with unexplained lung opacities, even with minimal symptoms.
  • Further research into SLC34A2 gene mutations and their role in PAM pathogenesis is warranted.

Related Concept Videos